Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -144,324 | -87,467 | -75,968 | -227,461 | -155,018 |
| Depreciation Amortization | 2,796 | 1,651 | 784 | -2,501 | -2,830 |
| Accounts receivable | 4,694 | 617 | -4,946 | 27,462 | 29,423 |
| Accounts payable and accrued liabilities | -3,043 | -5,726 | -1,881 | 706 | -3,415 |
| Other Working Capital | -55,078 | -59,727 | -9,146 | 8,900 | 24,635 |
| Other Operating Activity | 44,159 | 38,045 | 23,274 | 1,354 | -12,597 |
| Operating Cash Flow | $-150,796 | $-112,607 | $-67,883 | $-191,540 | $-119,802 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,511 | -1,260 | -1,174 | -3,098 | -2,030 |
| Purchase Of Investment | -260,911 | -170,973 | -142,380 | -461,521 | -335,490 |
| Sale Of Investment | 288,733 | 158,555 | 127,296 | 683,127 | 468,540 |
| Investing Cash Flow | $26,311 | $-13,678 | $-16,258 | $218,508 | $131,020 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -4,083 | -4,083 |
| Common Stock Issued | 1 | N/A | N/A | 96,798 | 96,798 |
| Other Financing Activity | 107 | 6 | 66 | 1,339 | 1,363 |
| Financing Cash Flow | $108 | $6 | $66 | $94,054 | $94,078 |
| Beginning Cash Position | 191,162 | 191,162 | 191,162 | 70,140 | 70,140 |
| End Cash Position | 66,785 | 64,883 | 107,087 | 191,162 | 175,436 |
| Net Cash Flow | $-124,377 | $-126,279 | $-84,075 | $121,022 | $105,296 |
| Free Cash Flow | |||||
| Operating Cash Flow | -150,796 | -112,607 | -67,883 | -191,540 | -119,802 |
| Capital Expenditure | -1,511 | -1,260 | -1,174 | -3,098 | -2,030 |
| Free Cash Flow | -152,307 | -113,867 | -69,057 | -194,638 | -121,832 |